An emerging pharmaceutical company headquartered in North America had successfully brought its first vaccine to market but lacked a foundational commercial data environment to support post‑launch execution. Data was sourced from multiple third‑party vendors and internal systems, with long turnaround...

A top‑five global pharmaceutical company with operations across Europe and other international markets lacked a consistent way to measure promotional effectiveness outside the United States. Marketing investment decisions in many regions were driven by intuition rather than data, limiting the organi...